Back to School: How biopharma can reboot drug development. Access exclusive analysis here

5G1.1: Began Phase Ib study

Alexion Pharmaceuticals Inc. (ALXN), New Haven, Conn.

Read the full 78 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE